NCT00257452View on ClinicalTrials.gov

A Double-blind, Randomised Study to Assess the Influence of Tiotropium (Spiriva®)

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Healthy
Interventions
DRUG

tiotropium 18 mcg or 54 mcg qd

DRUG

placebo matching tiotropium qd

DRUG

moxifloxacin 200 mg

Trial Locations (1)

55216

Humanpharmakologisches Zentrum, Ingelheim/Rhein

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY